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Abstract
Objectives: To determine whether and to what extent the additional application of plasma rich in
growth factors (PRGF) to an extraction socket may influence the early bone deposition, as assessed
by micro-computed tomography (micro-CT) scan as well as histomorphometric markers.
Material and methods: Twenty-eight patients (age range: 34–74 years) contributing 36 extraction
sockets were included in the study. Sockets were either treated with PRGF (PRGF group; 18 sites in
11 patients) or left to spontaneous healing (control group; 18 sites in 17 patients). Radiographic
and histomorphometric analysis was performed on bone cores trephined from each healing socket
after 4–6 (T1) or 7–10 (T2) weeks of healing.
Results: Patients treated with PRGF application showed (i) similar bone volume and tissue mineral
content, (ii) a trend, although not statistically significant, toward a greater number of CD68+ cells
(at T1 and T2) and vVW+ cells (at T1), and (iii) a similar OCN staining score throughout the study,
when compared with control group.
Conclusions: Plasma rich in growth factors-treated group did not show any enhancement in early
(4 and 8 weeks) bone deposition compared with control group.
The processes involved in the healing of an
extraction socket have been evaluated in dif-
ferent animal (Kuboki et al. 1988; Lin et al.
1994, 2011; Lekic et al. 2001; Cardaropoli
et al. 2003, 2005; Kanayama et al. 2003; Sato
& Takeda 2007; Vignoletti et al. 2012) and
human (Clafin 1936, Mangos 1941; Christo-
pher 1942; Amler et al. 1960, 1964; Boyne
1966; Amler 1969; Evian et al. 1982; Trom-
belli et al. 2008) models (see Farina & Trom-
belli 2012 for review). Recently, a study
conducted on human extraction sockets
reported that the rate of healing markedly
varies between subjects, and the process of
tissue remodeling, that is, the replacement of
woven bone with lamellar bone and marrow,
can be incomplete even at 24 weeks (Trom-
belli et al. 2008). Thus, while a provisional
connective tissue consistently forms within
the first weeks of healing, the interval during
which mineralized bone is laid down is much
less predictable. At present, the incomplete-
ness of the information regarding the timing
of bone deposition and maturation into the
healing socket as well as the wide variability
observed between individuals limit the possi-
bility to determine the proper time for
implant placement following tooth removal.
During the last decade, several studies
have been conducted to determine the poten-
tial role of biological agents and graft bioma-
terials in modulating the healing dynamics of
the extraction socket (Farina & Trombelli
2012). As a platelet concentrate, platelet-rich
plasma (PRP, i.e., preparations characterized
by a high concentration of platelets, obtain-
able by a single- or a double-step centrifuga-
tion of autologous blood) contains a number
of different growth factors, including PDGF,
TGF-b, and IGF (Okuda et al. 2003; Trombel-
li & Farina 2008), which may potentially
exert a positive effect on cell lines involved
in wound healing (Lacci & Dardik 2010) and
bone repair (Alsousou et al. 2009). Among
the available PRP preparations, PRGF tech-
nology enables the transformation of platelets
and endogenous fibrin potential into different
formulations with varying therapeutic poten-
tial (Anitua et al. 2007a, 2010). PRGF tech-
nology has given rise to an optimized and
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safer product known as PRGF, which circum-
vents many of the limitations of other
reported PRP and sealant products and offers
new perspectives for future regenerative pro-
cedures (Anitua 1999; Chen et al. 2010). In
particular, preliminary observational studies
indicated that PRGF may exert beneficial
effects when applied to healing sockets (Ani-
tua 1999; Nazaroglou et al. 2009; Mozzati
et al. 2010). PRGF has been claimed to
induce a faster re-epithelialization and a con-
sistently higher content of mineralized bony
trabeculae at 10–16 weeks after tooth extrac-
tion in humans (Anitua 1999).
The aim of the present clinical study was
to determine whether and to what extent the
additional application of PRGF to an extrac-
tion socket may influence the early bone
deposition, as assessed by micro-computed
tomography (micro-CT) as well as histomor-
phometric analysis.
Material and methods
Experimental design
The present study was designed as a parallel-
arm, open-label, controlled clinical trial and
conducted in alignment with a previously
published experimental model for the evalua-
tion of extraction socket healing in humans
(Trombelli et al. 2008).
Treatments were performed by three opera-
tors at three clinical centers. A clinical opera-
tor with specific training and clinical skill as
to the treatment with PRGF selected all
PRGF-treated sites, whereas the other two
trained clinical operators selected all control
sites (i.e., extraction sites left to spontaneous
healing). Each clinician performed all experi-
mental (either PRGF or control) procedures
from tooth extraction to biopsy collection.
Patient allocation to PRGF or control treat-
ment was dependent on which center he/she
attended for professional dental care.
All eligible subjects received detailed infor-
mation regarding the experimental protocol.
The type of information was dependent on
the treatment to be performed (extraction
with or without PRGF placement into the
socket). Each patient provided a written
informed consent before participation. All
the clinical procedures were performed in
accordance with the Declaration of Helsinki
and Good Clinical Practice Guidelines
(GCPs). Procedures for specimen processing
and histomorphometric analysis received a
determination of “not regulated status”
(approval code: HUM00054522) from the
Medical School Institutional Review Board,
University of Michigan (Ann Arbor, MI,
USA).
Study population
The following inclusion/exclusion criteria
were checked to determine the inclusion of
the subjects in the study:
1. Age. Subjects under 18 years were
excluded;
2. Health status. Subjects with positive
medical history for severe systemic
pathologies, acute or chronic, pregnant or
lactating women, subjects who assumed
drugs influencing osseous metabolism
(e.g., bisphosphonates, corticosteroids)
were excluded from the study.
Characteristics of extraction sockets
Eligibility criteria were represented by the
presence of at least one post-extraction site
related to the extraction of a single-rooted
tooth or single roots of hemisected mandibu-
lar molars. The following post-extraction
sites were excluded:
1. Oro-sinusal communication.
2. Endodontic periapical lesions with diam-
eter > 5 mm (radiographically deter-
mined).
3. Intraosseous component of the extraction
socket (i.e., the distance from the most
apical alveolar crest to the bottom of the
socket) <5 mm.
Extraction and post-extraction protocol
In all cases, the extraction procedures were
performed with a flapless approach. Roots of
mandibular molars were separated with rotat-
ing burs and scalpels avoiding any trauma to
the inter-radicular bone. All teeth/roots were
gently mobilized with luxators or elevators
and extracted with forceps, using rotational
movements and vertical traction to minimize
the trauma to the socket walls. In PRGF
group, PRGF was placed to fill the intraos-
seous component of the extraction defect.
Extraction sites were left to heal by second-
ary intention. If placed, sutures were
removed 1 week postoperatively. Local anti-
microbial therapy (CHX 0.12% mouthrinse;
10 ml t.i.d for 7 days) was prescribed. If an
infective complication required a systemic
antibiotic therapy, the extraction site was
excluded from the study.
PRGF preparation
Blood was obtained prior to administration of
anesthesia. Twenty ml of autologous blood
was drawn from the peripheral vein of each
patient and stored using 3.8% trisodium cit-
rate solution as anticoagulant. The tubes
were centrifuged at 580 g for 8 min (PRGF
System IV, BTI Biotechnology Institute, Vito-
ria, Spain) at room temperature. The blood
was separated into three basic components:
red blood cells, which appeared at the bottom
of the tube, PRGF in the middle of the tube,
and plasma poor in growth factors (PPGF) at
the top of the tube. The fraction (0.5 ml)
located immediately above the erythrocytes
was collected from each tube and transferred
to sterile tubes. This procedure results in a
platelet enrichment of PRGF ranging from
2.6-fold (0.5 9 106 platelets/ll) to 3.6-fold
(0.7 9 106 platelets/ll) over the baseline con-
centration in whole blood (Anitua et al.
2007b, 2011). The activation of PRGF was
accomplished with calcium chloride (50 lL at
10% added per 1-ml fraction of PRGF) 10–
15 min prior to PRGF placement in the
extraction socket.
Specimen harvesting procedure
The specimen harvesting procedure has been
previously described (Trombelli et al. 2008).
Briefly, before tooth extraction, an alginate
impression of the experimental area was
taken. On the cast model, a resin/silicon
stent was prepared and adapted on the teeth
adjacent to the tooth to be extracted. The
stent was used to determine the topographic
location of the extraction site during the
biopsy procedure by means of a reference
groove/hole prepared in correspondence to
the tooth to be extracted.
Immediately after tooth extraction, the dis-
tance from the stent to the bottom of the
alveolus was measured by means of a cali-
brated probe. This measurement ensured
that, at time of biopsy sampling, the trephine
bur collected the specimen in the area of
newly formed tissue, that is, coronal to the
original (post-extraction) location of the bot-
tom of the alveolus (thus avoiding to sample
the pre-existing bone).
Extraction sites of test group were treated
with PRGF. Control sites were left to sponta-
neous healing (i.e., without the additional
use of PRGF). Experimental procedures in
test and control site differed exclusively for
the use of PRGF.
Biopsies were scheduled at 4 weeks or
8 weeks after tooth extraction. After flap ele-
vation, the specimen was collected with a
trephine bur (internal ø: 2 mm, external ø:
3 mm). The minimal length of the specimen
was 5 mm. The specimen was collected at
the center of the socket, as determined by
the stent, with the bur kept parallel to the
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long axis of the adjacent tooth (or perpendic-
ular to the alveolar crest profile). The apical
portion of the specimen, once dried, was
marked with a fine indelible chine pen. If the
specimen was fragmented into (2/3) different
pieces, each fragment was separately stored,
and the exact apico-coronal orientation of the
specimen was maintained. In all cases, the
biopsy harvesting was performed concomi-
tantly with implant positioning at the experi-
mental site.
Micro-CT analysis
Non-decalcified extraction core specimens
were scanned at a resolution of 18 9 18
9 18 lm3 voxels using a Pxs5-928EA cone-
beam micro-CT system (GE Healthcare,
Little Chalfont, UK). GEHC MicroView
Analysis Plus® software (GE Healthcare) was
used to create three-dimensional (3D) recon-
structions of bone core specimens from the
scans as previously described (Park et al.
2007). Region of interest (RoI) was repre-
sented by the entire extraction core or frag-
mented tissues samples. Threshold gray-
scale value was determined for each speci-
men by a single masked and calibrated
examiner (A.T.). The average threshold gray-
scale value was calculated and used as the
representative value to assess bone volume
(BV) and tissue mineral content (TMC). Tis-
sue mineral density (TMD) was calculated
for all extraction core specimens as TMC/
BV.
Histological evaluation
Specimen storage and processing
The collected specimens were immediately
fixed in 10% formalin until micro-CT analy-
sis. Following lCT scanning, extraction cores
were decalcified for 2 weeks in 10% ethylene
diaminetetraacetic acid (EDTA) at 4°C, trans-
ferred to 70% ethanol, and stored at 4°C
until paraffin embedding. Specimens were
embedded in paraffin, cut into 5 lm sagittal
plane sections, and mounted on slides. Sec-
tions representing the central-most portion of
the bone core were chosen for histological
and immunohistochemical staining purposes.
Selected sections were stained with hema-
toxylin and eosin, as well as Masson’s tri-
chrome. Remaining unstained slides were
used to perform immunohistochemical stain-
ing to identify the presence of vasculature/
endothelial cells (von Willebrand factor –
vWF), osteoblasts/bone matrix synthesis
(Osteocalcin – OCN), and macrophages, giant
cells (CD68). In preparation for immunohis-
tochemical staining, paraffin-embedded sec-
tions were de-paraffinized in xylene (2 9
2 min) and rehydrated through graded alco-
hols. For von Willebrand factor and CD68
antibodies, antigen retrieval was performed
using a Decloaking Chamber (Biocare Medi-
cal, Walnut Creek, CA, USA) where slides
were immersed in 19 Target Retrieval Solu-
tion (Dako, Glostrup, Denmark) and boiled
for 2 min at 125°C and 5 min at 100°C,
respectively, and then allowed to cool at
room temperature for approximately 45 min
(Nor et al. 2001). Immunohistochemical
staining was completed using the manufac-
turer instructions of the appropriate antibody
detection kit. Primary antibody incubations
were performed at room temperature for the
recommended time. 0.1% Tris-phosphate-
buffered saline (TPBS) was used as the wash
buffer, and diaminobenzidine (DAB) as the
substrate/chromogen for all immunohisto-
chemical staining procedures. Sections were
rinsed in phosphate-buffered saline (PBS) and
distilled water, counterstained, and mounted.
For each antibody tested, one section was
incubated in serum and served as the nega-
tive control.
Histomorphometric analysis
The histomorphometric analysis was carried
out by a single calibrated examiner (A.T.),
masked as to the treatment allocation codes
and observational interval.
Histological and immunohistochemical
images were captured using Nikon Eclipse
50i microscope (Nikon Inc., Melville, NY,
USA) fitted with a Nikon Digital Sight DS
U1 camera (Nikon Inc.). Quantitative histo-
morphometric analysis was completed using
NIS Elements Basic Research imaging soft-
ware (Nikon Inc.). The central-most portion
of the extraction core was chosen for histo-
morphometric analysis, and standardized
RoIs in the coronal, middle, and apical por-
tions of the sample were analyzed (Kaigler
et al. 2010). The RoI was sized to encompass
functionally relevant regions of the sample
and also provide a standardized viewing win-
dow at 209 magnification.
Red-green-blue (RGB) colorimetric thres-
holding values were identified, yielding the
most representative depiction of dark brown
DAB labeling within each RoI. The average
RGB intensity value was calculated for vWF
and CD68 immunohistochemical staining
and used to individually quantify the number
of cells and area coverage. In the NIS Ele-
ments Basic Research software, groups of
neighboring pixels are defined as objects. The
number of objects was assumed to correlate
to the number of vWF- and CD68-positive
cells (objects measuring <10 lm3 were eclud-
ed to prevent the quantification of artifacts).
The area of positive DAB staining corre-
sponded to area occupied by vWF- and CD68-
positive cells.
Average pixel intensity (ranging from 0 to
255) was used to quantify the relative expres-
sion of OCN in tissue. Low pixel intensities
corresponded to the color black, while the
highest intensities indicating the presence of
white, with the brown DAB substrate mea-
suring approximately 150. Thus, the OCN
score was inversely correlated to average
pixel intensity (a.p.i.): a.p.i = 180192: score
3; a.p.i = 192.0001204: score 2;
a.p.i = 204.0001216: score 1;
a.p.i = 216.0001 or above: score 0.
Statistical analysis
The patient was regarded as the statistical
unit. For patients contributing multiple sites,
data were averaged to give a patient value.
Data were entered in a unique database and
analyzed using a statistical software (STAT-
ISTICA; Statsoft Italia, Vigonza, Italy). Data
were expressed as mean and standard devia-
tion (SD) as well as median and interquartile
range (IR). Comparisons were performed
using v2 test, Fisher’s test, and Mann–Whit-
ney U-test.
Bone volume was regarded as the primary
outcome variable. As data on BV to evaluate
the healing process of human extraction
sockets could not be retrieved, a post hoc
power analysis was performed. Assuming a
standard deviation in BV of 2.0 mm3 and an
expected inter-group difference in BV of
2.0 mm3, 1.5 mm3, or 1.0 mm3, a sample of
10 patients (five patients/group) had a power
of 89.0%, 56.2%, 35.0%, respectively, in
detecting a significant inter-group difference
(at P = 0.05).
Results
Study population and protocol deviations
Twenty-eight patients (mean age: 55.2 years,
minimum-maximum values: 34–74 years; 13
males, 15 females) contributing 36 extraction
sites were included in the study.
Control group
Seventeen patients (mean age: 57.0 years,
range: 34–74 years; eight males, nine females)
contributed 18 extraction sites. Teeth were
extracted owing to root fracture (n = 9), caries
(n = 3), implant-supported prosthetic treat-
ment planning (n = 5), or failure of endodon-
tic treatment (n = 1).
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Eight specimens in seven patients (mean age:
61.4 years, range: 51–74 years; three males,
four females) were collected after 4 weeks of
healing. Ten specimens in 10 patients (mean
age: 53.9 years, range: 34–73 years; five males,
five females) scheduled for biopsy at 8 weeks
were collected after 7 weeks (three sites) or
8 weeks (seven sites) of healing.
PRGF group
Eleven patients (mean age: 51.0 years, range:
42–64 years; five males, six females) contrib-
uted 18 extraction sites. Teeth were extracted
owing to severe bone loss (destructive peri-
odontitis) (n = 6), root fracture (n = 5), caries
(n = 4), implant-supported prosthetic treat-
ment planning (n = 2), or failure of endodon-
tic treatment (n = 1).
Eleven specimens in six patients (mean age:
51.2 years, range: 48–57 years; three males,
three females) scheduled for biopsy at 4 weeks
were collected after 4 weeks (nine sites in four
patients), 5 weeks (one site), or 6 weeks (one
site) of healing. Seven specimens in five
patients (age: 54.0 years, range: 42–64 years;
two males, three females) scheduled for biopsy
at 8 weeks were collected after 8 weeks (four
sites in three patients), 9 weeks (two sites in
one patient), or 10 weeks (one site) of healing.
Specimens harvested after 4–6 weeks and 7
–10 weeks were pooled for data analysis into
two distinct observation intervals: T1 and
T2, respectively.
The CONSORT flow chart of the study is
illustrated in Fig. 1. Patient- and site-related
characteristics of PRGF and control groups
are reported in Table 1. Treatment groups
were significantly different for smoking sta-
tus (P < 0.001).
Micro-CT analysis
Representative micro-CT scans of the study
specimens in control and PRGF groups are
reported in Fig. 2.
Bone volume (mm3), TMC (mg), and TMD
(mg/cm3) in control and PRGF groups are
shown in Table 2.
In the control group, newly formed bone
occupied a variable part of the specimen at
T1. Although a trend toward greater BV and
Fig. 1. Flow chart of the study.
Table 1. Patient- and site-related characteristics in PRGF and control groups
Control PRGF P value
Patient level
Number of patients T1 7 6 –
T2 10 5
Age (years) Mean 57.0 52.5 0.175
Median 60.0 51.0
Range 34–74 42–64
Gender (number of females) 9 6 1
Smoking status (smokers/former
smokers/never smoked)
0/5/12 5/5/1 <0.001
Site level
Number of sites T1 8 11 –
T2 10 7
Site distribution according to tooth type
(incisor/canine/
premolar/single root of mandibular molar)
T1 2/2/4/0 1/2/6/2 N.D.
T2 4/0/5/1 0/0/7/0 N.D.
Site distribution according to location
(maxillary/mandibular)
T1 7/1 5/6 0.026
T2 6/4 5/2 1
N.D. – not determined
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TMC values was evident at T2, the difference
in BV and TMC from T1 to T2 did not reach
the statistical significance.
In PRGF group, limited BV and TMC were
observed at T1. Both BV and TMC showed a
slight (not statistically significant) increase at
T2. No significant differences in BV and
TMC were observed between groups at either
T1 or T2.
In both control and PRGF groups, a simi-
lar TMD was observed between T1 and T2.
No significant differences in TMD were
observed between groups at either T1 or T2
(Table 2).
Histomorphometric analysis
Five specimens in four control patients and
six specimens in four PRGF patients were
suitable for histomorphometric analysis at
T1. At T2, histomorphometric assessment
was performed on seven specimens in seven
control patients and five specimens in four
PRGF patients (Fig. 1). Specimens that exhib-
ited significant damage or large artifacts were
excluded from the histomorphometric analy-
sis. Also omitted from the histomorphomet-
ric analysis were tissue sections not
representative of the most central portion of
the bone core. Representative specimens for
each immunohistochemical staining in con-
trol and PRGF groups at T1 and T2 are
reported in Fig. 3.
CD68
A tendency to show a higher number of
CD68+ cells was observed in PRGF group at
T1 and T2; however, no significant differ-
ences were found between groups at both
observation intervals (Table 3). While an
increase in CD68+ cells was observed from
T1 to T2 in control group, a slight decrease
occurred in PRGF group. However, within-
group changes in the number of CD68+ cells
were not statistically significant for both
groups (Table 3).
von Willebrand factor
The number of vWF+ objects, which was
assumed to correlate to the number of vWF+
cells, was higher, although not statistically
significantly, at T1 in PRGF compared with
control group (Table 3). In contrast, similar
presence of vWF+ cells (assessed as either
number of objects or area) was observed at T2,
owing to a decrease (although not significant)
in vWF+ cells in the PRGF group (Table 3).
Osteocalcin
Osteocalcin score showed a statistically sig-
nificant decrease from T1 to T2 for both con-
trol and PRGF group (P = 0.006 and
P = 0.029, respectively). No significant differ-
ences in OCN score were observed between
groups at both observation intervals
(Table 3).
Discussion
The present study was performed to evaluate
the early phases of bone deposition in human
Fig. 2. Representative micro-CT scans of the study
specimens in control and PRGF groups.
Table 2. Results of micro-CT analysis: bone volume (BV, mm3), tissue mineral content (TMC, mg), and tissue mineral density (TMD, mg/cm3). Data are
expressed as mean and standard deviation (SD) as well as median and interquartile range (IR)
Bone volume (mm3) Tissue mineral content (mg) Tissue mineral density (mg/cm3)
Control PRGF P value Control PRGF P value Control PRGF P value
T1 Mean (SD) 3.1 (3.4) 1.4 (2.0) 0.177 1.8 (2.0) 0.7 (1.0) 0.177 519.4 (123.5) 480.0 (97.6) 0.329
Median (IR) 2.5 (0.6–4.6) 0.3 (0–2.6) 1.5 (0.3–2.6) 0.2 (0–1.3) 567.5 (466.6–603.2) 460.8 (445.9–477.2)
T2 Mean (SD) 4.5 (2.7) 3.2 (2.9) 0.792 2.5 (1.7) 1.7 (1.8) 0.662 538.4 (106.6) 485.8 (73.1) 0.429
Median (IR) 4.7 (2.2–7.0) 3.0 (1.1–3.8) 2.4 (1.0–3.7) 1.4 (0.5–2.1) 524.6 (445.9–599.1) 464.3 (435.7–520.4)
P value 1 0.247 0.927 0.247 0.788 1
Fig. 3. Representative specimens for each immunohistochemical staining in control and PRGF groups. Black arrows
depict vWF/Factor VIII-positive endothelial cells forming blood vessels. Black triangles represent CD68-positive
macrophages. Asterisks depict the osteocalcin-positive early-stage and mature mineralized tissue matrix.
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extraction sockets treated with PRGF.
Twenty-eight patients (age range: 34–
74 years) contributing 36 extraction sockets
were included in the study. Sockets were
either treated with PRGF or left to spontane-
ous healing. Within the limits of the present
study, the results indicate that patients trea-
ted with PRGF application showed (i) similar
bone volume and tissue mineral content, (ii)
a trend, although not statistically significant,
toward a greater number of CD68+ cells (at
T1 and T2) and vVW+ cells (at T1), and (iii) a
similar OCN staining score throughout the
study, compared with control patients.
In control group, spontaneous healing was
characterized by a progressive increase
(although not statistically significant) of BV
and TMC from T1 to T2, while TMD
remained similar over time. Consistently,
several studies on healing sockets in humans
indicated that woven bone increases during
the first weeks of healing, partly replacing
granulation tissue (Amler et al. 1960; Evian
et al. 1982; Trombelli et al. 2008). In particu-
lar, Trombelli et al. (2008) reported that the
mean proportion of the newly formed tissue
occupied by bone showed an increase from
6.9% at 2–4 weeks to 34.0% at 6–8 weeks
(Trombelli et al. 2008). The trend toward an
increased bone deposition was paralleled by a
significant increase in OCN content at T2
compared with T1. In a previous study, a
higher density of OCN-positive cells lining
the woven bone trabeculae was seen at sam-
ples collected at 6–8 weeks of healing com-
pared with samples collected after 2–4 weeks
(Trombelli et al. 2008). Overall, these results
support an increased bone modeling activity
during the first 8–10 weeks of healing, lead-
ing to the progressive deposition of woven
bone from provisional matrix. In our mate-
rial, new bone formation was associated with
the persistence of vWF+ cells at T2, which is
compatible with the substantial volume still
occupied by the granulation tissue observed
at early healing phase (Trombelli et al. 2008).
Previous findings demonstrated a similar
density of vascular units (as assessed by
CD31-positive cells) at 2–4 compared with 6–
8 weeks, whereas a substantial decrease was
observed only at a later stage (12–24 weeks)
(Trombelli et al. 2008).
In our study protocol, PRGF was selected
among the known PRP preparations for appli-
cation in extraction sockets. PRGF consists
of a leukocyte-free, platelet-rich preparation
obtained by one-step centrifugation of plasma
and treated with sodium citrate as anticoagu-
lant, and calcium chloride as activator (Ani-
tua et al. 2007a, 2008). Several advantages
were advocated for PRGF compared with
other PRP formulations (Chen et al. 2010).
The use of PRGF technology obviates immu-
nological reactions and the risk of disease
transmission associated with the use of exog-
enous substances (e.g., thrombin). The
absence of leukocytes improves the physical
characteristics of the preparation and mini-
mizes the presence of leukocyte-related pro-
inflammatory factors (e.g., metalloproteases,
acid hydrolases) (Weibrich et al. 2005; Schna-
bel et al. 2007; Dohan Ehrenfest et al. 2009).
The use of calcium chloride as clot activator
results in significantly higher concentrations
of growth factors (Tsay et al. 2005).
At T1 and T2, similar BV and TMC were
evident in PRGF and control groups. This
observation was paralleled by the histomor-
phometric findings showing similar OCN
scores between groups throughout the study.
In contrast, recent data from human studies
(Alissa et al. 2010; Rutkowski et al. 2010;
Ce´lio-Mariano et al. 2012) seem to suggest
that PRP preparations, other than PRGF, may
to some extent accelerate bone deposition in
the early phases of the healing of extraction
sockets. However, the beneficial effects on
bone density tend to reduce overtime. The
effect of PRP on tissue healing is a function
of many variables, including platelet concen-
tration, the volume of PRP delivered, the
extent and type of injury, and the overall
medical condition of the patient (Alsousou
et al. 2009). The procedure for PRP prepara-
tion significantly affects the content in plate-
lets and, consequently, growth factors levels
(Weibrich et al. 2005). Previous in vitro stud-
ies have demonstrated that PRP may exert a
dose-specific effect on osteoblasts and osteo-
clasts, cell differentiation and proliferation
being affected by high platelet concentration
of the preparate (Arpornmaeklong et al. 2004;
Graziani et al. 2006; Cenni et al. 2010). Posi-
tive effects on in vivo bone formation were
observed for platelet concentration in PRP
preparations of about 106 platelets/ll (Weib-
rich et al. 2004), which exceeds those
observed in PRGF preparations (Anitua et al.
2007b, 2011).
Previous observations on PRGF reported
more mature bone with better organized tra-
beculae and greater bone regeneration in
PRGF-treated extraction sockets compared
with control sites at 10–16 weeks after tooth
extraction (Anitua 1999). Discrepancies in
the results between studies may be partly
ascribed to methodological issues. In the
Anitua study, healing extraction sites were
not quantitatively evaluated, the analysis
of re-epithelialization and bone formation/T
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maturation being merely based on histologic
observations (Anitua 1999). Moreover, in five
of 10 experimental sockets, PRGF treatment
was combined with an additional autologous
bone graft (ABG). Previous studies demon-
strated that ABG per se may influence the
healing process in extraction sockets (Becker
et al. 1994, 1996). Since in Anitua study biop-
sies were collected at longer time intervals
compared with our study, the possibility that
the effects of PRGF on new bone formation
may become manifest at a later stage cannot
be excluded.
Although not statistically significant, an
increased density of CD68-positive cells was
observed in PRGF-treated patients compared
with controls at T1 and T2. Some hypotheses
may be advanced to explain the macrophag-
es/giant cells infiltrate in the presence of an
autologous platelet concentrate. First, soft
tissues overlying an extraction site grafted
with PRGF seem to express higher levels of
some pro-inflammatory cytokines (Mozzati
et al. 2010), thus potentially contributing to
the recruitment of monocytes/macrophages.
Second, autologous platelet concentrates may
favor the expression of specific adhesion mol-
ecules on the endothelial cell membrane
(Cenni et al. 2009), favoring an increased che-
motaxis for monocytes/macrophages. In par-
ticular, ICAM-1 recruits monocytes to the
bone-healing site, so as to promote the
inflammatory reaction during the first phases
of bone repair. Therefore, it was suggested
that PRP may contribute to the macrophage
response in the inflammatory phase, which is
essential for a correct bone repair (Cenni
et al. 2009). In contrast, previous studies
where osseous defects have been treated with
a platelet-released growth factors (obtained
after centrifugation of washed, thrombin-acti-
vated cells of PRP) suggest that the increased
recruitment of monocytes/macrophages and
osteoclastogenesis exerted by an autologous
platelet concentrate may result in an
impaired early bone formation (Fuerst et al.
2004).
As angiogenesis plays a pivotal role in bone
healing, vWF immunostaining was used to
evaluate the presence of endothelial cells
and, consequently, vascular structures in the
wound area. In this respect, autologous plate-
let concentrates seem to modulate the prolif-
eration, motility, and invasiveness of human
endothelial cells (Roussy et al. 2007; Rughet-
ti et al. 2008; Cenni et al. 2009; Mooren
et al. 2010), partly through VEGF released by
platelet a-granules (Cenni et al. 2009). In par-
ticular, the proangiogenic effect has been
shown in vitro for platelet concentrations
similar to (Rughetti et al. 2008) or higher
than (Cenni et al. 2009) those present in
PRGF. Consistently, in our material, PRGF
treatment resulted in a trend toward an
increased amount of vWF+ cells at T1 com-
pared with control sites. These data seem to
suggest that the local application of PRGF in
extraction sockets may promote an angio-
genic burst during the early stage of healing,
which seems to subside over time.
Smokers were unevenly distributed between
treatments, the prevalence being higher in
PRGF group. Pre-clinical evidence indicates
that smoking may affect bone metabolism at
extraction sites through a modulation of the
expression of genes encoding for the key mole-
cules of bone healing. A trend toward the
down-regulation of bone morphogenetic pro-
tein 2 and alkaline phosphatase and the up-
regulation of the receptor activator of nuclear
factor kappa-B ligand/osteoprotegerin ratio
was reported, suggesting that smoking could
be detrimental to new bone formation (Giorg-
etti et al. 2010). Few clinical studies have
investigated the effect of smoking on the heal-
ing of extraction sockets in humans. In this
respect, Saldanha et al. (2006) showed that
smoking may negatively affect radiographic
bone density as well as the extent of the
dimensional reduction occurring after tooth
extraction. Thus, it is possible to hypothesize
that PRGF may have counterbalanced the
potential negative effect of smoking on early
bone formation. Unfortunately, a sub-analysis
to explore the role of smoking on PRGF-
induced healing dynamics was not feasible
owing to the limited sample size of subgroups.
In our study, the selection of all patients
was based on stringent inclusion criteria;
however, the treatment of all cases in PRGF
group was assigned to one clinician with a
documented expertize in PRGF technology.
Although a selection bias owing to lack of
randomization cannot be excluded, this
design may have optimized the clinical effi-
cacy of PRGF treatment as well as reduced
the potential variability associated with
PRGF preparation and clinical use.
In conclusion, our results indicate that
patients treated with PRGF application
showed (i) similar bone volume and tissue
mineral content, (ii) a trend, although not
statistically significant, toward a greater
number of CD68+ cells (at T1 and T2) and
vVW+ cells (at T1), and (iii) a similar OCN
staining score throughout the study, com-
pared with control patients. Within its limits,
the present study revealed that PRGF-treated
group did not show any enhancement in
early (4 and 8 weeks) bone deposition com-
pared with control group. In our study, the
effect of PRGF was merely investigated in
extraction sockets from single-rooted teeth or
single roots of mandibular molars. Although
no attempt was made to assess the volume of
the extraction socket (or the extracted root)
immediately after surgery, such selection
may have reduced the inter-site differences
in healing dynamics owing to the variability
in socket dimension. On the other hand,
treatment of defects of limited size may have
masked and underestimated the true biologic
potential of PRGF on early bone formation.
Further controlled studies are needed to
assess which type of post-extraction condi-
tions, including patient characteristics as
well as dimension and morphology of the
socket, may represent an indication for the
additional use of PRGF. Also, other potential
benefits, including reduced incidence of alve-
olar osteitis (Rutkowski et al. 2007), lower
post-extraction pain, and enhanced quality of
soft tissue healing (Alissa et al. 2010), may
indicate PRGF treatment in extraction sock-
ets.
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